arct: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	1,694	469
Net decrease in cash, cash equivalents and restricted cash	-56,668	-40,561
Cash and cash equivalents at beginning of period	293,913	-
Cash and cash equivalents at end of period	237,245	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	1,694	469
Net decrease in cash, cash equivalents and restricted cash	-56,668	-40,561
Cash and cash equivalents at beginning of period	293,913	-
Cash and cash equivalents at end of period	237,245	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Arcturus Therapeutics Holdings Inc. (ARCT)